Welcome Rchris1962, and thank you for your input.
Post# of 148279
I originally invested in this company 5.5 years ago when it was solely HIV, so all of the new indications were unexpected.
Perhaps you can help me with a question I have long had.
I think we can agree that Leronlimab is a more effective treatment than HAART, but how adventageous to you think the sub-q injection is vs pills? What percentage of the HIV population do you think would rather do a sub-q injection than take pills?